App-Quantinova.ai

Do AMP-Activated Protein Kinase (AMPK) and Metformin Play a Role in the Small Intestine in Normal and Pathophysiological Conditions?

Elodie Harmel - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

Carnitine

Development of Obesity, Insulin Resistance and Metabolic Derangements in Mice Overexpressing Sar1b Whose Mutation Causes Chylomicron Retention Disease

Carole Garofalo - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Chylomicron retention disease

N/A

Reduced Expression of Colonic Mucosal IL-10 mRNA in Irritable Bowel Syndrome: a Meta-Analysis

Nima Rezaei - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Irritable Bowel Syndrome

Interleukin-10

Ileal RNA-Seq Analyses Reveal Decreased Mucosal Myeloid Cell Immune Responses in Pediatric Crohn Disease Patients With Phagocyte Dysfunction Due to Neutralizing Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Auto-Antibodies

Ingrid Jurickova - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Dysbiosis

L-Tyrosine

Transcutaneous Intraluminal Impedance Measurements (TIIM): a New Minimally-Invasive Technique for Long-Term Monitoring of Gastric Motility

Anas Hussain - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Functional Dyspepsia

Neostigmine

Cysteinyl Leukotrienes Activate Mouse Intestinal Vagal Afferent Nerves

Sung Jin Park - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Montelukast

Cross-Talk Exists Between Mechanosensitive Cation Channel and Potassium Channels in Vagal Afferent Neurons and Is Altered in Obesity

Michael J. Beyak - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

GsMTx4

A Novel Function for Estrogen Receptor GPR30: Control of Gastrointestinal Motility and Visceral Sensation

Salar Habibi - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Irritable Bowel Syndrome

Bethanechol Chloride

A Comparison of Sedation and Non-Sedation Colonoscopy Focus on Costs and Utilization

Matt Chamblee - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Propofol

Treatment of Crohn's Disease With Anti-Tumor Necrosis Factor Decreases Levels of C-Reactive Protein: a Systematic Review and Meta-Analysis

Isabelle A. Vallerand - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Crohn's disease

Certolizumab pegol

Incidence of Venous Thromboembolism in Gastrointestinal Bleeding

Nilesh Chande - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Gastrointestinal bleeding

dalteparin Subcutaneous

The Impact of Obesity on Operative and Post-Operative Outcomes After Colorectal Cancer Surgery - a Meta-Analysis

Alan N. Barkun - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Colorectal Cancer

N/A

Effects of Vitamin D Supplementation on Intestinal Permeability, Plasma Cathelicidin and Human Beta-Defensin-2 in Crohn's Disease: Results From a Randomised Double-Blind Placebo-Controlled Study

Adrian Martineau - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Crohn's disease

Ergocalciferol

Pharmacokinetics and Exposure-Response Relationship of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Phase2/3 Induction and Maintenance Studies

Zhenhua Xu - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

golimumab

Sustained Efficacy in Patients With Ulcerative Colitis Treated With Adalimumab: Results From ULTRA 2

Douglas C. Wolf - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Adalimumab

Efficacy of Serum-Derived Bovine Immunoglobulin Protein Isolate (SBI) in Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Eric Weaver - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Irritable Bowel Syndrome

N/A

Safety of Adalimumab in Global Clinical Trials of Ulcerative Colitis Patients

Subrata Ghosh - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Adalimumab

Rates of Patient-Defined Remission With Adalimumab in Patients With Ulcerative Colitis: Subanalysis of ULTRA 1 and ULTRA 2

James D. Lewis - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Adalimumab

Clostridium difficile Infection Emergency Department Visits in the United States: Patterns of Care, Admission and Mortality

Mohammad Yaghoobi - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Clostridium difficile infection

N/A

Burden of Clostridium difficile-Associated Hospitalizations in the United States

Mohammad Yaghoobi - Digestive Disease Week (DDW) , 2013

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Clostridium difficile infection

N/A

Filters

28841 Abstracts